I can't remember the exact wordings but he said they will have enough data from the trial by the end of the year if not a lot sooner. The trial will most likely be finished shortly in the way there will be enough data to justify moving on to the larger second round trial while still remaining open is my understanding. I personally would like a lot more transparency from management. If anyone from Imagion is reading this please give us an update so we can avoid any confusion.
Ann: Half-Year Investor Presentation, page-48
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
